John Lich

John Lich is currently a Scientific Director at GlaxoSmithKline, where they focus on cell-based assay development. They previously held various research and teaching positions at the University of North Carolina at Chapel Hill and were a principal scientist and investigator at GSK since 2011. John earned a Ph.D. in Immunology from the Indiana University School of Medicine and has extensive experience in innate and adaptive immunology, molecular immunology, and systems biology. Their earlier roles included fellowships and research positions that contributed to their deep expertise in biochemistry, proteomics, and signal transduction analysis.